Caseware UK (AP4) 2024.0.164 2024.0.164 2024-04-01false15truedental practice activities17trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 04756995 2024-04-01 2025-03-03 04756995 2023-04-01 2024-03-31 04756995 2025-03-03 04756995 2024-03-31 04756995 c:Director5 2024-04-01 2025-03-03 04756995 d:Buildings d:ShortLeaseholdAssets 2024-04-01 2025-03-03 04756995 d:Buildings d:ShortLeaseholdAssets 2025-03-03 04756995 d:Buildings d:ShortLeaseholdAssets 2024-03-31 04756995 d:PlantMachinery 2024-04-01 2025-03-03 04756995 d:PlantMachinery 2025-03-03 04756995 d:PlantMachinery 2024-03-31 04756995 d:PlantMachinery d:OwnedOrFreeholdAssets 2024-04-01 2025-03-03 04756995 d:MotorVehicles 2024-04-01 2025-03-03 04756995 d:MotorVehicles 2025-03-03 04756995 d:MotorVehicles 2024-03-31 04756995 d:MotorVehicles d:OwnedOrFreeholdAssets 2024-04-01 2025-03-03 04756995 d:FurnitureFittings 2024-04-01 2025-03-03 04756995 d:FurnitureFittings 2025-03-03 04756995 d:FurnitureFittings 2024-03-31 04756995 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-04-01 2025-03-03 04756995 d:OfficeEquipment 2024-04-01 2025-03-03 04756995 d:OfficeEquipment 2025-03-03 04756995 d:OfficeEquipment 2024-03-31 04756995 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-03 04756995 d:OtherPropertyPlantEquipment 2024-04-01 2025-03-03 04756995 d:OtherPropertyPlantEquipment 2025-03-03 04756995 d:OtherPropertyPlantEquipment 2024-03-31 04756995 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2024-04-01 2025-03-03 04756995 d:OwnedOrFreeholdAssets 2024-04-01 2025-03-03 04756995 d:Goodwill 2024-04-01 2025-03-03 04756995 d:Goodwill 2025-03-03 04756995 d:Goodwill 2024-03-31 04756995 d:CurrentFinancialInstruments 2025-03-03 04756995 d:CurrentFinancialInstruments 2024-03-31 04756995 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-03 04756995 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 04756995 d:ShareCapital 2025-03-03 04756995 d:ShareCapital 2024-03-31 04756995 d:RetainedEarningsAccumulatedLosses 2025-03-03 04756995 d:RetainedEarningsAccumulatedLosses 2024-03-31 04756995 c:FRS102 2024-04-01 2025-03-03 04756995 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-03 04756995 c:FullAccounts 2024-04-01 2025-03-03 04756995 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-03 04756995 d:Goodwill d:OwnedIntangibleAssets 2024-04-01 2025-03-03 04756995 e:PoundSterling 2024-04-01 2025-03-03 iso4217:GBP xbrli:pure
Registered number: 04756995













Hudson Cosmedic Limited

Financial statements
Information for filing with the registrar

3 March 2025




 
Hudson Cosmedic Limited


Balance sheet
At 3 March 2025

3 March
31 March
2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 4 
43,333
80,000

Tangible assets
 5 
334,212
531,892

  
377,545
611,892

Current assets
  

Stocks
  
27,225
27,500

Debtors
 6 
562,008
279,565

Cash at bank and in hand
  
831,871
411,093

  
1,421,104
718,158

Creditors: amounts falling due within one year
 7 
(373,987)
(235,480)

Net current assets
  
 
 
1,047,117
 
 
482,678

Total assets less current liabilities
  
1,424,662
1,094,570

Provisions for liabilities
  

Deferred tax
  
(47,239)
(90,214)

Net assets
  
1,377,423
1,004,356


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
1,377,323
1,004,256

Shareholders' funds
  
1,377,423
1,004,356


1

 
Hudson Cosmedic Limited

    
Balance sheet (continued)
At 3 March 2025

The directors consider that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 September 2025.




R A Paxman
Director

Registered number: 04756995
The notes on pages 3 to 9 form part of these financial statements. 
2

 
Hudson Cosmedic Limited
 
 

Notes to the financial statements
Period ended 3 March 2025

1.


General information

Hudson Cosmedic Limited ('the company') is a private company limited by shares, incorporated and domiciled in the United Kingdom and registered in England and Wales. The address of the registered office is Monmouth House, Blackbrook Business Park, Taunton, Somerset, TA1 2PX

2.Accounting policies

 
2.1

Statement of compliance

The financial statements have been prepared in accordance with Section 1A of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and the Republic of Ireland (FRS 102) and the Companies Act 2006.

 
2.2

Revenue

The turnover shown in the profit and loss account represents private fees and capitation income receivable during the period.

 
2.3

Current and deferred taxation

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


3

 
Hudson Cosmedic Limited
 

 
Notes to the financial statements
Period ended 3 March 2025

2.Accounting policies (continued)

 
2.4

Intangible assets

Goodwill

Goodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight-line basis to the statement of comprehensive income over its useful economic life.

Other intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Goodwill
-
10
years

 
2.5

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Short-term leasehold property
-
6%
straight line
Plant and machinery
-
10%
straight line
Bicycles
-
25%
reducing balance
Fixtures and fittings
-
10%
straight line
Office equipment
-
20%
reducing balance
Motor vehicles
-
25%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

4

 
Hudson Cosmedic Limited
 

 
Notes to the financial statements
Period ended 3 March 2025

2.Accounting policies (continued)

 
2.6

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.7

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.8

Financial instruments

The company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and
5

 
Hudson Cosmedic Limited
 

 
Notes to the financial statements
Period ended 3 March 2025

2.Accounting policies (continued)


2.8
Financial instruments (continued)

loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Employees

The average monthly number of employees, including directors, during the period was 17 (2024 - 15).


4.


Intangible assets






Goodwill

£



Cost


At 1 April 2024
400,000



At 3 March 2025

400,000



Amortisation


At 1 April 2024
320,000


Charge for the period
36,667



At 3 March 2025

356,667



Net book value



At 3 March 2025
43,333



At 31 March 2024
80,000



6

 
Hudson Cosmedic Limited
 
 

Notes to the financial statements
Period ended 3 March 2025

5.


Tangible fixed assets







Short-term leasehold property
Plant and machinery
Bicycles
Fixtures and fittings
Office equipment

£
£
£
£
£



Cost


At 1 April 2024
245,827
560,829
35,159
66,610
33,688


Additions
-
571
-
835
650


Disposals
-
(32,874)
(35,159)
-
-



At 3 March 2025

245,827
528,526
-
67,445
34,338



Depreciation


At 1 April 2024
89,113
332,020
13,171
47,107
11,899


Charge for the period
13,520
51,433
5,039
6,078
4,016


Disposals
-
(10,958)
(18,210)
-
-



At 3 March 2025

102,633
372,495
-
53,185
15,915



Net book value



At 3 March 2025
143,194
156,031
-
14,260
18,423



At 31 March 2024
156,714
228,809
21,988
19,504
21,789
7

 
Hudson Cosmedic Limited
 
 

Notes to the financial statements
Period ended 3 March 2025

           5.Tangible fixed assets (continued)


Motor vehicles
Total

£
£



Cost


At 1 April 2024
107,983
1,050,096


Additions
-
2,056


Disposals
(103,914)
(171,947)



At 3 March 2025

4,069
880,205



Depreciation


At 1 April 2024
24,894
518,204


Charge for the period
19,041
99,127


Disposals
(42,170)
(71,338)



At 3 March 2025

1,765
545,993



Net book value



At 3 March 2025
2,304
334,212



At 31 March 2024
83,088
531,892


6.


Debtors

3 March
31 March
2025
2024
£
£


Trade debtors
25,107
5,100

Other debtors
528,781
266,149

Prepayments and accrued income
8,120
8,316

562,008
279,565


8

 
Hudson Cosmedic Limited
 
 

Notes to the financial statements
Period ended 3 March 2025

7.


Creditors: amounts falling due within one year

3 March
31 March
2025
2024
£
£

Trade creditors
67,422
51,908

Corporation tax
262,770
167,776

Other taxation and social security
7,424
3,753

Other creditors
1,319
6,403

Accruals and deferred income
35,052
5,640

373,987
235,480


 
9